2026-01-01 - Analysis Report
Okay, let's break down this Exxon Mobil (XOM) analysis step-by-step.

**1. Return Rate Comparison with S&P 500 (VOO)**

*   **XOM Overview:** Exxon Mobil Corp is a major integrated oil and gas company.
*   **XOM Cumulative Return:** 25.63%
*   **VOO Cumulative Return:** 102.21%
*   **Divergence:** -76.6 (Relative Divergence: 18.9)

    *   This indicates that XOM has significantly underperformed the S&P 500 over the analyzed period. The relative divergence suggests XOM's underperformance is near its historical worst relative to VOO.

*   **Alpha, Beta Analysis Table (2024-2026):**

    *   **CAGR (31.0%):**  Projected average annual growth rate.
    *   **MDD (81.8%):**  Maximum Drawdown â€“ a significant potential loss.
    *   **Alpha (-74.0%):** Indicates underperformance compared to a benchmark (likely the market). A negative alpha is bad.
    *   **Beta (0.0):**  XOM is not very influenced by market movements or there is an error in the calculation.
    *   **Cap (B) (512.4):**  Market capitalization in billions.

    *   **Analysis:** The table paints a mixed picture. While the projected CAGR is high, the massive MDD and negative Alpha are major red flags. A beta of 0 is unusual.

**2. Recent Stock Price Fluctuations**

*   **Current Close:** 120.99
*   **Last Market Data:** Price: 120.2, Previous Close: 120.99, Change: -0.65 (Slight decrease)
*   **5-day SMA:** 119.85
*   **20-day SMA:** 118.06
*   **60-day SMA:** 116.11

    *   **Analysis:** The stock price is trending upward, as indicated by the ascending moving averages (5-day > 20-day > 60-day). The recent price decrease is reflected in the slightly lower price than yesterday's.

**3. Indicators Analysis**

*   **MRI (0.9):**  High Investment Recommended.  This suggests the market risk is considered to be in an acceptable band for investment.
*   **RSI (59.24):**  Neutral.  Neither overbought nor oversold.
*   **PPO (0.25):**  Positive, suggesting a slight upward trend.
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (8 shares - Safe - MRI:0.80) suggests a strong buy signal with the model suggesting buying shares with most of available cash. The model calculates MRI to be slightly lower (0.8) with this investment decision.
*   **Recent Divergence Change:** 2.2 (+) - short-term rise.
*   **Expected Return:** -124.2% - Expected underperformance compared to the S&P 500 in the long term.
*   **Recent Price Fluctuation:** Price decrease from 120.99 to 120.2 indicates recent selling pressure.

    *   **Analysis:** The signals are mixed. The MRI is positive, and the moving average trend suggests an upward price movement. However, the expected return is extremely negative, signaling significant concerns about long-term investment in XOM relative to the market.

**4. Recent News & Significant Events**

*   **Key Themes from News:**
    *   Institutional buying (Perigon Wealth Management)
    *   Discussion of past performance (Motley Fool - 10-year returns)
    *   Focus on refining success and demand resilience (Zacks, Globe and Mail)
    *   Analyst target prices and oil price movements (ts2.tech)

    *   **Analysis:** Recent news presents a mixed picture. Some articles highlight positive aspects like resilient demand and institutional buying, while others discuss past performance and analyst targets, some of which might be cautious.

**4-2. Analyst Opinions**

*   **Consensus:** Buy (Mean: 2.22)
*   **Target Price:** Average: 131.56, High: 158.00, Low: 109.00

    *   **Analysis:** Analysts, on average, have a "Buy" rating and expect the stock price to rise to around $131.56. However, the range of target prices is wide, suggesting some uncertainty among analysts. Lack of recent rating changes is also a source of concern.

**5. Comprehensive Analysis**

Overall, the analysis of Exxon Mobil (XOM) presents a complex and somewhat contradictory picture.

*   **Positives:**
    *   Recent upward price trend indicated by moving averages.
    *   Positive MRI suggesting acceptable market risk (although, based on the table results, it may need re-evaluation.)
    *   Analyst consensus is "Buy" with a potential upside target price.
    *   Recent news highlights some positive aspects of the company's refining business and resilient demand.

*   **Negatives:**
    *   Significant underperformance compared to the S&P 500.
    *   Very negative Alpha and Expected Return, indicating concerns about long-term investment.
    *   High Maximum Drawdown suggests substantial risk.
    *   The significant divergence from S&P 500 should be a cause for concern.
    *   Recent drop in Price.
    *   The calculated beta of 0 may indicate a problem with the data.

*   **Recommendation:**

    *   Based on this analysis, a cautious approach is warranted. While some short-term indicators are positive, the significant underperformance compared to the S&P 500 and the extremely negative expected return should be carefully considered.
    *   It is recommended to further investigate the reasons for the underperformance and the basis for the negative expected return before making any investment decisions.
    *   The high MDD indicates that there is high risk to the investment.

In summary, while there are some short-term positive signals, the long-term outlook for XOM, relative to the broader market, appears concerning based on this data. The high MDD suggests that the stock carries a higher degree of risk compared to the market.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.